Back Atlanticcouncil Pfizer CEO Albert Bourla on AI and the future of medicine
Pfizer Chairman and CEO Albert Bourla joined Frederick Kempe to how artificial intelligence is transforming the healthcare industry. From drug discovery to clinical research and beyond, they explore the opportunities and challenges ahead. Bourla also addresses the role business and government play in ensuring innovation keeps pace with rapid technological advances.
This conversation took place during the Atlantic Council’s #ACinNY programming on the sidelines of the United Nations General Assembly.
Listen to Inflection Points with Frederick Kempe wherever you get podcasts
Hosted by Frederick Kempe, president and CEO of the Atlantic Council and long-time Wall Street Journal editor and reporter, each episode goes beyond the headlines to explore the forces driving geopolitics, economics, technological change, and global leadership.
Drawing on Kempe’s decades of experience as a journalist, author, and historian, as well as his personal relationships with many of today’s key decisionmakers, Inflection Points with Frederick Kempe offers intimate, substantive conversations with global leaders and influential thinkers on the inflection points transforming the world.
Inflection Points with Frederick Kempe
Candid conversations with the leaders and thinkers shaping the global future.
Image: AC in NY ACFP - Pfizer's Albert Bourla on AI, health and innovation in a changing world on September 22, 2026 at The St. Regis New York. Photography by Clarissa Villondo
The full story
This article is one source in a clustered incident — the cluster page carries the summary, timeline and every other outlet covering it.
